BELLEVUE GROUP AG Halozyme Therapeutics, Inc. Transaction History

BELLEVUE GROUP AG portfolio value:

$36.79M
portfolio value

BELLEVUE GROUP AG quarter portfolio value change:

-10.14%
quarter

Halozyme Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -4.20% -40.8K shares -5.94M $39.54 930.5K
Q2 2022 share Decrease -5.17% -52.9K shares 1.89M $44 971.3K
Q1 2022 share Decrease -4.06% -43.3K shares -2.07M $39.88 1.02M
Q4 2021 share Increase +15.84% 146K shares 5.43M $40.32 1.06M
Q3 2021 share Decrease -58.57% -1.30M shares -63.52M $40.68 921.5K
Q2 2021 share Decrease -26.15% -787.5K shares -24.55M $45.41 2.22M
Q1 2021 share Decrease -25.54% -1.03M shares -47.19M $41.69 3.01M
Q4 2020 share Decrease -26.04% -1.42M shares 29.03M $42.71 4.04M
Q3 2020 share Decrease -18.74% -1.26M shares -36.71M $26.28 5.46M
Q2 2020 share Decrease -12.18% -933.40K shares 42.57M $26.81 6.73M
Q1 2020 share Decrease -4.64% -372.9K shares -4.61M $17.99 7.66M
Q4 2019 share Increase +0.28% 22.5K shares 18.19M $17.73 8.03M
Q3 2019 share Decrease -2.83% -233.50K shares -17.39M $15.51 8.01M
Q2 2019 share Increase 0.00% 8.24M shares 141.69M $17.18 8.24M
Q2 2018 share Decrease -100.00% -75.8K shares -1.48M $16.87 0
Q1 2018 share Decrease -1.56% -1.2K shares -75K $19.59 75.8K
Q4 2017 share Decrease -12.10% -10.6K shares 38K $20.26 77K
Q3 2017 share Decrease -60.00% -131.4K shares -1.28M $17.37 87.6K
Q2 2017 share Decrease -18.89% -51K shares -691K $12.82 219K
Q1 2017 share Decrease -15.09% -48K shares 357K $12.96 270K
Q4 2016 share 0.00% 0 shares -699K $9.88 318K
Q3 2016 share 0.00% 0 shares 1.09M $12.08 318K
Q2 2016 share 0.00% 0 shares -267K $8.63 318K
Q1 2016 share Increase 0.00% 318K shares 3.01M $9.47 318K